Research & Development

Montgomery County’s life sciences sector offers cell and gene therapy companies unparalleled proximity to the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI), and the broader federal biomedical research community. This unique concentration of institutions provides direct access to world-class scientific talent, regulatory expertise, and translational research infrastructure, creating a significant competitive advantage for companies developing and commercializing next-generation therapies.

Companies across the County are developing therapeutics targeting oncology, rare diseases, neuroscience, infectious diseases, and immune-mediated conditions, reflecting the depth and diversity of the local biotechnology ecosystem. The presence of both commercial-stage and clinical-stage innovators is a testament to the County’s strength in advancing therapies from development through commercialization.

Montgomery County’s contract research and research services sector benefits from strong connections to federal biomedical agencies, leading research institutions, nonprofit organizations, and biopharmaceutical companies. This concentration of expertise supports specialized capabilities in clinical research, biomedical informatics, regulatory science, program management, and evidence generation, helping accelerate innovation and bring new therapies and technologies to market.

Montgomery County’s biomanufacturing and process technology companies encompass expertise across vaccine production, biologics tools, assay platforms, cell-based technologies, and life sciences manufacturing systems. Together, these capabilities strengthen the life sciences sector and support advanced biologics through every stage of development, scale-up, and commercialization.

Companies developing diagnostics, monitoring technologies, laboratory platforms, and specialized clinical tools are advancing innovations that improve disease detection, patient monitoring, and clinical decision-making across a range of healthcare and life sciences applications. Attracted by a highly educated workforce and strong quality of life, these companies are well positioned to attract and retain top talent, as well as secure new investment to support continued growth and innovation.

A growing digital health and AI-enabled diagnostics sector brings together companies working across genomics, diagnostics, patient engagement, healthcare analytics, and AI-driven biomedical discovery. Here, they benefit from access to world-class research institutions, a highly skilled talent pool, and a collaborative life sciences environment that supports innovation and commercialization.